125 related articles for article (PubMed ID: 37527782)
1. A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer.
Cohen AT; Wallenhorst C; Choudhuri S; Nassar A; Pollock KG; Martinez C
Thromb Haemost; 2024 Apr; 124(4):324-336. PubMed ID: 37527782
[TBL] [Abstract][Full Text] [Related]
2. Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.
Martinez C; Katholing A; Wallenhorst C; Cohen AT
Br J Haematol; 2020 May; 189(3):524-533. PubMed ID: 31997309
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
[TBL] [Abstract][Full Text] [Related]
4. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
5. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
Palareti G; Legnani C; Antonucci E; Cosmi B; Falanga A; Poli D; Mastroiacovo D; Pengo V; Ageno W; Testa S
Ther Adv Drug Saf; 2021; 12():20420986211062965. PubMed ID: 34987749
[TBL] [Abstract][Full Text] [Related]
6. Natural history of cancer-associated splanchnic vein thrombosis.
Shang H; Jiang JY; Guffey D; Novoa F; Bandyo R; Ma S; Li A
J Thromb Haemost; 2024 May; 22(5):1421-1432. PubMed ID: 38309433
[TBL] [Abstract][Full Text] [Related]
7. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
[TBL] [Abstract][Full Text] [Related]
8. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
Shaw JR; Douketis J; Le Gal G; Carrier M
J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
[TBL] [Abstract][Full Text] [Related]
9. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes.
Brunton NE; Wysokinski WE; Hodge DO; Vlazny DT; Houghton DE; Casanegra AI
Res Pract Thromb Haemost; 2021 May; 5(4):e12500. PubMed ID: 34027287
[TBL] [Abstract][Full Text] [Related]
10. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism.
Zakai NA; Walker RF; MacLehose RF; Adam TJ; Alonso A; Lutsey PL
J Thromb Haemost; 2018 Dec; 16(12):2403-2412. PubMed ID: 30240508
[TBL] [Abstract][Full Text] [Related]
11. Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism.
Cambron JC; Saba ES; McBane RD; Casanegra AI; Villarraga HR; Houghton DE; Vlazny DT; Froehling D; Hodge D; Peterson LG; Bott-Kitslaar DM; Wysokinski WE
Mayo Clin Proc Innov Qual Outcomes; 2020 Jun; 4(3):249-258. PubMed ID: 32542216
[TBL] [Abstract][Full Text] [Related]
12. Direct Oral Anticoagulants in Patients With Active Cancer: A Systematic Review and Meta-Analysis.
Sabatino J; De Rosa S; Polimeni A; Sorrentino S; Indolfi C
JACC CardioOncol; 2020 Sep; 2(3):428-440. PubMed ID: 34396250
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study.
Xu J; Wang G; Chen X; Shen Y; Wang X; Wang H
Thromb J; 2023 Feb; 21(1):15. PubMed ID: 36726149
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status.
Cohen AT; Sah J; Dhamane AD; Lee T; Rosenblatt L; Hlavacek P; Emir B; Keshishian A; Yuce H; Luo X
Adv Ther; 2021 Nov; 38(11):5519-5533. PubMed ID: 34570310
[TBL] [Abstract][Full Text] [Related]
15. Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism.
Houghton DE; Vlazny DT; Casanegra AI; Brunton N; Froehling DA; Meverden RA; Hodge DO; Peterson LG; McBane RD; Wysokinski WE
Mayo Clin Proc; 2021 Nov; 96(11):2793-2805. PubMed ID: 34425962
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies.
Guan T; Laguna A; Soares A; Legasto CS; Block S; Saunders IM; Alvarez K; Pon T; Patel N; Mahajan A; Lee A
J Thromb Thrombolysis; 2023 Oct; 56(3):439-446. PubMed ID: 37421494
[TBL] [Abstract][Full Text] [Related]
17. Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
Pawar A; Gagne JJ; Gopalakrishnan C; Iyer G; Tesfaye H; Brill G; Chin K; Bykov K
JAMA; 2022 Mar; 327(11):1051-1060. PubMed ID: 35289881
[TBL] [Abstract][Full Text] [Related]
18. Bleeding complications in patients on new oral anticoagulants for venous thromboembolism in Kenya.
Obayo A; Ngunga M; Shah J; Sokwala A; Barasa A
Cardiovasc J Afr; 2022 Jul-Aug 23; 33(4):186-192. PubMed ID: 35118489
[TBL] [Abstract][Full Text] [Related]
19. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
[TBL] [Abstract][Full Text] [Related]
20. Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events.
Poénou G; Tolédano E; Helfer H; Plaisance L; Happe F; Versini E; Diab N; Djennaoui S; Mahé I
Front Cardiovasc Med; 2023; 10():1132156. PubMed ID: 37671139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
